106 related articles for article (PubMed ID: 1326470)
41. Amplification and specific detection of transforming gene region of human papillomavirus 16, 18 and 33 in cervical carcinoma by means of the polymerase chain reaction.
Shimada M; Fukushima M; Mukai H; Kato I; Nishikawa A; Fujinaga K
Jpn J Cancer Res; 1990 Jan; 81(1):1-5. PubMed ID: 2157691
[TBL] [Abstract][Full Text] [Related]
42. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A
Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877
[TBL] [Abstract][Full Text] [Related]
43. Overexpression and amplification of c-myc and c-Ha-ras oncogenes in pleomorphic salivary adenoma.
Xue H; Situ ZQ; Wang CJ; Wu JZ
Chin Med J (Engl); 1993 Jan; 106(1):22-5. PubMed ID: 8389270
[TBL] [Abstract][Full Text] [Related]
44. Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas.
Dürst M; Croce CM; Gissmann L; Schwarz E; Huebner K
Proc Natl Acad Sci U S A; 1987 Feb; 84(4):1070-4. PubMed ID: 3029760
[TBL] [Abstract][Full Text] [Related]
45. Ha-ras oncogene-induced transcription of human papillomavirus type 18 E6 and E7 oncogenes.
Medina-Martínez O; Vallejo V; Guido MC; García-Carrancá A
Mol Carcinog; 1997 Jun; 19(2):83-90. PubMed ID: 9210955
[TBL] [Abstract][Full Text] [Related]
46. Alterations in exon 1 of c-myc and expression of p62c-myc in cervical squamous cell carcinoma.
O'Leary JJ; Landers RJ; Crowley M; Healy I; Kealy WF; Hogan J; Doyle CT
J Clin Pathol; 1997 Nov; 50(11):896-903. PubMed ID: 9462237
[TBL] [Abstract][Full Text] [Related]
47. Identification of HPV 16 early genes retained in cervical carcinomas.
Wilczynski SP; Pearlman L; Walker J
Virology; 1988 Oct; 166(2):624-7. PubMed ID: 2845667
[TBL] [Abstract][Full Text] [Related]
48. Demonstration of multiple HPV types in normal cervix and in cervical squamous cell carcinoma using the polymerase chain reaction on paraffin wax embedded material.
Griffin NR; Bevan IS; Lewis FA; Wells M; Young LS
J Clin Pathol; 1990 Jan; 43(1):52-6. PubMed ID: 2155946
[TBL] [Abstract][Full Text] [Related]
49. Human papilloma virus infection and Ki-ras oncogene in paraffin-embedded squamous carcinomas of the cervix.
Falcinelli C; Luzi P; Alberti P; Cosmi EV; Anceschi MM
Gynecol Obstet Invest; 1993; 36(3):185-8. PubMed ID: 8244195
[TBL] [Abstract][Full Text] [Related]
50. Analysis of ras point mutations and human papillomavirus 16 and 18 in cervical carcinomata and their metastases.
Willis G; Jennings B; Ball RY; New NE; Gibson I
Gynecol Oncol; 1993 Jun; 49(3):359-64. PubMed ID: 8390962
[TBL] [Abstract][Full Text] [Related]
51. Abnormal expression of pan-ras, c-myc and tp53 in squamous cell carcinoma of cervix: correlation with HPV and prognosis.
Ngan HY; Cheung AN; Liu SS; Cheng DK; Ng TY; Wong LC
Oncol Rep; 2001; 8(3):557-61. PubMed ID: 11295080
[TBL] [Abstract][Full Text] [Related]
52. Comparison of Southern blot analysis with isotopic and nonisotopic in situ hybridization for the detection of human papillomavirus sequences in invasive carcinoma of the uterine cervix.
D'Amato L; Pilotti S; Rotola A; Di Luca D; Cassai E; Rilke F
Mod Pathol; 1992 Mar; 5(2):207-11. PubMed ID: 1315439
[TBL] [Abstract][Full Text] [Related]
53. Expression and splicing patterns of human papillomavirus type-16 mRNAs in pre-cancerous lesions and carcinomas of the cervix, in human keratinocytes immortalized by HPV 16, and in cell lines established from cervical cancers.
Sherman L; Alloul N; Golan I; Durst M; Baram A
Int J Cancer; 1992 Feb; 50(3):356-64. PubMed ID: 1310488
[TBL] [Abstract][Full Text] [Related]
54. Search for human papillomavirus, herpes simplex virus and c-myc oncogene in human genital tumors.
Di Luca D; Costa S; Monini P; Rotola A; Terzano P; Savioli A; Grigioni W; Cassai E
Int J Cancer; 1989 Apr; 43(4):570-7. PubMed ID: 2539328
[TBL] [Abstract][Full Text] [Related]
55. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
[TBL] [Abstract][Full Text] [Related]
56. Adenocarcinoma in situ of the uterine cervix: clinicopathological study of nine cases with detection of human papillomavirus DNA by in situ hybridization and polymerase chain reaction.
Alejo M; Macedo I; Matias-Guiu X; Prat J
Int J Gynecol Pathol; 1993 Jul; 12(3):219-23. PubMed ID: 8393844
[TBL] [Abstract][Full Text] [Related]
57. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
[TBL] [Abstract][Full Text] [Related]
58. Distinct patterns of alteration of myc genes associated with integration of human papillomavirus type 16 or type 45 DNA in two genital tumours.
Sastre-Garau X; Favre M; Couturier J; Orth G
J Gen Virol; 2000 Aug; 81(Pt 8):1983-1993. PubMed ID: 10900037
[TBL] [Abstract][Full Text] [Related]
59. Newly established uterine cervical carcinoma cell line with co-amplification of human papillomavirus DNA and c-myc gene.
Gotoh M; Nakajima T; Yokota J; Tsunokawa Y; Terada M; Shimoyama Y; Teshima S; Hirohashi S; Shimosato Y
Jpn J Cancer Res; 1991 Nov; 82(11):1252-7. PubMed ID: 1721614
[TBL] [Abstract][Full Text] [Related]
60. Response to radiotherapy of human uterine cervix carcinoma is not correlated with rearrangements of the Ha-ras-1 and/or c-myc genes.
Polischouk AG; Scotnikova OI; Sergeeva NS; Zharinov GM; Lewensohn R; Zhivotovsky B
Eur J Cancer; 1997 May; 33(6):942-9. PubMed ID: 9291819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
